Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 43, doi. 10.1007/s00228-007-0408-z
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2008 AND VI 64 AND IP 1
Results: 16
1
2
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP[TM]) predicts in vivo metabolic inhibition.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 1, doi. 10.1007/s00228-007-0391-4
- By:
- Publication type:
- Article
4
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 25, doi. 10.1007/s00228-007-0398-x
- By:
- Publication type:
- Article
5
The conscientious judgement of a DSMB - statistical stopping rules re-examined.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
6
Development of NSAIDs prescription indicators based on health outcomes.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 61, doi. 10.1007/s00228-007-0384-3
- By:
- Publication type:
- Article
7
Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 17, doi. 10.1007/s00228-007-0389-y
- By:
- Publication type:
- Article
8
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 73, doi. 10.1007/s00228-007-0386-1
- By:
- Publication type:
- Article
9
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 77, doi. 10.1007/s00228-007-0387-0
- By:
- Publication type:
- Article
10
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 31, doi. 10.1007/s00228-007-0396-z
- By:
- Publication type:
- Article
11
Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 89, doi. 10.1007/s00228-007-0395-0
- By:
- Publication type:
- Article
12
Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 51, doi. 10.1007/s00228-007-0392-3
- By:
- Publication type:
- Article
13
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 83, doi. 10.1007/s00228-007-0388-z
- By:
- Publication type:
- Article
14
The conscientious judgement of a DSMB – statistical stopping rules re-examined.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 69, doi. 10.1007/s00228-007-0403-4
- By:
- Publication type:
- Article
15
CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 9, doi. 10.1007/s00228-007-0385-2
- By:
- Publication type:
- Article
16
Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.
- Published in:
- 2008
- By:
- Publication type:
- Letter